Stuart Mealing is an Associate Director of York Health Economics Consortium and leads the Consortium’s health economic modelling and patient reported outcomes workstream. He is a member of NICE’s Highly Specialised Technologies Evaluation Committee and the NIHR Invention for Innovation (I4I) Challenge award committee. Stuart has a Master’s degree in Operational Research from the University of Lancaster Business School and a Postgraduate Certificate in International Business Management from Smurfit Business School, Dublin.

Stuart has worked in numerous therapy areas including oncology (solid tumour and haematological), cardiology (devices and pharmaceuticals), pulmonology, ophthalmology and neurology. Stuart has extensive experience in the development and review of cost-effectiveness and budget impact models, and has particular experience in working with orphan/ultra-orphan conditions as well as the use of a range of survival analysis techniques. In addition, Stuart has experience of performing and managing a range of projects covering statistical data analysis, evidence synthesis, literature review and the development of reimbursement submissions. Stuart is an author on over 65 peer reviewed publications and monographs and before joining YHEC, Stuart was the EU Head of Health Economics at ICON Clinical Research Ltd. Before that he worked as a researcher at PenTAG, one of the research groups that perform independent assessments for NICE.